Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Pathogenesis of glucocorticoid...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
Pathogenesis of glucocorticoid osteoporosis: Role of tyrosine phosphatases
Bibliographic Details
Main Authors:
Hulley, P
,
Conradie, M
,
Engelbrecht, Y
,
Titus, C
,
Hough, F
Format:
Journal article
Published:
2001
Holdings
Description
Similar Items
Staff View
Similar Items
Glucocorticoid-induced osteoporosis in the rat is prevented by the tyrosine phosphatase inhibitor, sodium orthovanadate.
by: Hulley, P, et al.
Published: (2002)
The tyrosine phosphatase inhibitor vanadate protects osteoblasts from growth inhibition by glucocorticoids.
by: Hulley, P, et al.
Published: (1999)
Vanadate protects osteoblasts in vitro and in vivo from glucocorticoid impairment of proliferation
by: Hulley, P, et al.
Published: (2002)
Glucocorticoids induce rapid up-regulation of mitogen-activated protein kinase phosphatase-1 and dephosphorylation of extracellular signal-regulated kinase and impair proliferation in human and mouse osteoblast cell lines.
by: Engelbrecht, Y, et al.
Published: (2003)
Mitogen-activated protein kinase phosphatase 1/dual specificity phosphatase 1 mediates glucocorticoid inhibition of osteoblast proliferation.
by: Horsch, K, et al.
Published: (2007)